Advertisement

Topics

TRACT Therapeutics, Inc. Company Profile

15:32 EDT 21st September 2018 | BioPortfolio

TRACT Therapeutics, Inc. is a clinical-stage biotechnology company developing a novel therapeutic approach to restoring immune balance in transplantation and autoimmune disease. It’s proprietary platform technology, using autologous, polyclonally expanded T-regulatory cells was developed at Northwestern University by pioneer, Joseph R Leventhal, MD, PhD and his research colleagues. TRACT plans to file for Orphan Drug Designation for organ transplantation in 2016. For more information, visit our web site at: www.tracttherapeutics.com


News Articles [968 Associated News Articles listed on BioPortfolio]

New Antibiotic for Urinary Tract Infections Gets Positive Phase II Results

Allecra Therapeutics has obtained positive Phase II study results for its new urinary tract infection antibiotic, supporting the launch of a Phase III trial. Allecra Therapeutics, a French-German bio...

Iterum begins SURE 1 trial for uncomplicated urinary tract infections

Iterum Therapeutics has commenced the first Sulopenem for Resistant Enterobacteriaceae (SURE) trial, a Phase lll study of oral sulopenem against...Read More... The post Iterum begins SURE 1 trial for ...

Urinary Tract Infections Pipeline Highlights – 2017 Update – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Urinary Tract Infections Pipeline Highlights – 2017 Update” drug pipelines has been added to ResearchAndMarkets.com’s offering. Urinary ...

Leap Therapeutics nets $15.1mm through public offering

Leap Therapeutics Inc. publicly sold 2.1mm common shares (including the overallotment) at $7.50 for net proceeds of $15.1mm. The company is developing cancer treatments and plans to use some of the pr...

Left ventricular outflow tract (LVOT) obstruction (LVOTO): The Role of CT in TAVR and in TMVR

Left ventricular outflow tract (LVOT) obstruction (LVOTO): The Role of CT in TAVR and in TMVR Reporter: Aviva Lev-Ari, PhD, RN   Left ventricular outflow tract obstruction (LVOTO) is a recognise...

Urinary Tract Infections Pipeline Insight, 2018 [Report Updated: 14022018] Prices from USD $1250

"Urinary Tract Infections Pipeline Insight, 2018 report by DelveInsight offers comprehensive Insight of the pipeline under development therapeutics scenario and growth prospects across Urinary Tract ...

Recurrent lower respiratory tract infections in children

What you need to knowRecurrent lower respiratory tract infection can be regarded as ≥3 annual episodes of documented bronchitis, bronchiolitis, or pneumonia and may merit further investigation for a...

Nabriva nets $47mm via FOPO

Anti-infectives developer Nabriva Therapeutics PLC netted $47mm through the follow-on public offering of 18.18mm ordinary shares at $2.75 each. Nabriva recently announced it was acquiring Zavante Ther...

PubMed Articles [1141 Associated PubMed Articles listed on BioPortfolio]

Meropenem/vaborbactam (Vabomere) for complicated urinary tract infection.

Along-tract analysis of the arcuate fasciculus using the Laplacian operator to evaluate different tractography methods.

We propose a new along-tract algorithm to compare different tractography algorithms in tract curvature mapping and along-tract analysis of the arcuate fasciculus (AF). In particular, we quantified alo...

Inconsistency in the definition of urinary tract infection after intravesical botulinum toxin A injection: a systematic review.

In order to more accurately examine the rate of urinary tract infection following onabotulinumtoxinA injection of the bladder, we systematically reviewed the literature for definitions of urinary trac...

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

High molecular weight hyaluronic acid: a two-pronged protectant against infection of the urogenital tract?

Recurrent urinary tract infections are associated with uropathogenic (UPEC) ascending and infecting the urinary tract. Antibiotics provide only symptomatic relief, not prevent recurrence. Clinical ev...

Clinical Trials [1361 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Lower Urinary Tract Infection (UTI) Evaluation in Women With Uterine Leiomyomata

To the investigators knowledge there is no research data published to date regarding the lower urinary tract symptoms in women with leiomyomas. The primary aims of this study are: 1. T...

Companies [1310 Associated Companies listed on BioPortfolio]

TRACT Therapeutics, Inc.

TRACT Therapeutics, Inc. is a clinical-stage biotechnology company developing a novel therapeutic approach to restoring immune balance in transplantation and autoimmune disease. I...

Solace Therapeutics Inc.

Solace Therapeutics is dedicated to developing innovative, non-surgical and clinically effective devices that address unmet needs in lower urinary tract symptoms (LUTS). Our initi...

Solace Therapeutics, Inc.

Solace Therapeutics is an emerging medical device company focused on the development of non-surgical office based treatments for common bladder disorders, such as stress urinary incontinence (SUI), ov...

Avaxia Biologics, Inc.

Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal ...

Kala Pharmaceuticals, Inc.

Kala Pharmaceuticals, Inc. is a leading developer of improved treatments for diseases that affect mucosal tissues. Using its proprietary mucus penetrating particle (MPP) technolog...

More Information about "TRACT Therapeutics, Inc." on BioPortfolio

We have published hundreds of TRACT Therapeutics, Inc. news stories on BioPortfolio along with dozens of TRACT Therapeutics, Inc. Clinical Trials and PubMed Articles about TRACT Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of TRACT Therapeutics, Inc. Companies in our database. You can also find out about relevant TRACT Therapeutics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Transplantation
Organ transplantation is the moving of an organ from one body to another or from a donor site to another location on the patient's own body, for the purpose of replacing the recipient's damaged or absent organ. The emerging field of regenerative ...

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...


Corporate Database Quicklinks



Searches Linking to this Company Record